3-Ethyl-6-{4-[4-(4-fluoro-phenyl)-4-oxo-butyl]-piperazin-1-ylmethyl}-2-methyl-1,5,6,7-tetrahydro-indol-4-one

ID: ALA163605

Chembl Id: CHEMBL163605

PubChem CID: 10455878

Max Phase: Preclinical

Molecular Formula: C26H34FN3O2

Molecular Weight: 439.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1c(C)[nH]c2c1C(=O)CC(CN1CCN(CCCC(=O)c3ccc(F)cc3)CC1)C2

Standard InChI:  InChI=1S/C26H34FN3O2/c1-3-22-18(2)28-23-15-19(16-25(32)26(22)23)17-30-13-11-29(12-14-30)10-4-5-24(31)20-6-8-21(27)9-7-20/h6-9,19,28H,3-5,10-17H2,1-2H3

Standard InChI Key:  NWIRMMHLUWBLSN-UHFFFAOYSA-N

Associated Targets(Human)

HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor and serotonin 2a receptor (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Htr2a Serotonin 2a (5-HT2a) receptor (3540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2b Serotonin 2b (5-HT2b) receptor (321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2b Serotonin receptor 2a and 2b (5HT2A and 5HT2B) (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2c Serotonin receptor 2a and 2c (5HT2A and 5HT2C) (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.58Molecular Weight (Monoisotopic): 439.2635AlogP: 4.05#Rotatable Bonds: 8
Polar Surface Area: 56.41Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.03CX LogP: 3.67CX LogD: 3.51
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.63Np Likeness Score: -0.87

References

1. Brea J, Rodrigo J, Carrieri A, Sanz F, Cadavid MI, Enguix MJ, Villazón M, Mengod G, Caro Y, Masaguer CF, Raviña E, Centeno NB, Carotti A, Loza MI..  (2002)  New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.,  45  (1): [PMID:11754579] [10.1021/jm011014y]
2. Masaguer CF, Ravina E, Loza I, Fontenla J.  (1997)  New cyclic butyrophenone derivatives in the indole series as potential atypical antipsychotics. A simple and practical synthesis of 6-aminomethyl-tetrahydroindol-4-ones and their affinites for D2 and 5-HT2A receptors,  (7): [10.1016/S0960-894X(97)00131-5]

Source